ARDX Stock Price
Ardelyx, Inc.
ARDX stock price is $3.19 (+2.24% on the day), giving Ardelyx, Inc. a market cap of $777.47M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ARDX Stock Overview
- Price
- $3.19
- Previous close
- $3.12
- Open
- $3.10
- Market cap
- $777.47M
- P/E ratio
- -12.6
- 52-week range
- $3.18 - $8.40
- 1-year price target
- $12.90
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 39
About Ardelyx, Inc.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARDX | $3.19 | +2.2% | 5.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |